Intellipharmaceutics International Inc. Quarterly Common Stock, Value, Issued in USD from Q4 2010 to Q3 2023

Taxonomy & unit
us-gaap: CAD and USD
Description
Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.
Summary
Intellipharmaceutics International Inc. quarterly Common Stock, Value, Issued history and growth rate from Q4 2010 to Q3 2023.
  • Intellipharmaceutics International Inc. Common Stock, Value, Issued for the quarter ending August 31, 2023 was $49.2M, unchanged year-over-year.
Common Stock, Value, Issued, Quarterly (USD)
Common Stock, Value, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2023 $49.2M $0 0% Aug 31, 2023 6-K 2023-10-16
Q2 2023 $49.2M $0 0% May 31, 2023 6-K 2023-09-26
Q1 2023 $49.2M $0 0% Feb 28, 2023 6-K 2023-09-26
Q4 2022 $49.2M $0 0% Nov 30, 2022 20-F/A 2024-02-06
Q3 2022 $49.2M $0 0% Aug 31, 2022 6-K 2022-10-14
Q2 2022 $49.2M $0 0% May 31, 2022 6-K 2022-07-21
Q1 2022 $49.2M +$3.03M +6.57% Feb 28, 2022 6-K 2022-04-14
Q4 2021 $49.2M +$3.03M +6.57% Nov 30, 2021 20-F/A 2024-02-06
Q3 2021 $49.2M +$3.03M +6.57% Aug 31, 2021 6-K 2021-10-15
Q2 2021 $49.2M +$3.03M +6.57% May 31, 2021 6-K 2021-07-15
Q1 2021 $46.1M $0 0% Feb 28, 2021 6-K 2021-04-14
Q4 2020 $46.1M +$583K +1.28% Nov 30, 2020 20-F/A 2022-05-09
Q3 2020 $46.1M +$583K +1.28% Aug 31, 2020 6-K 2020-10-15
Q2 2020 $46.1M +$809K +1.78% May 31, 2020 6-K 2020-07-15
Q1 2020 $46.1M +$863K +1.91% Feb 29, 2020 6-K 2020-05-29
Q4 2019 $45.6M +$1.23M +2.78% Nov 30, 2019 20-F 2021-03-31
Q3 2019 $45.6M +$6.86M +17.7% Aug 31, 2019 6-K 2019-10-11
Q2 2019 $45.3M +$6.64M +17.2% May 31, 2019 6-K 2019-07-10
Q1 2019 $45.3M Feb 28, 2019 6-K 2019-04-15
Q4 2018 $44.3M +$9.04M +25.6% Nov 30, 2018 20-F 2020-03-30
Q3 2018 $38.7M Aug 31, 2018 6-K 2018-10-15
Q2 2018 $38.7M May 31, 2018 6-K/A 2018-07-24
Q4 2017 $35.3M Nov 30, 2017 6-K 2018-10-15
Q4 2015 $21.5M +$2.54M +13.4% Nov 30, 2015 20-F 2016-03-21
Q4 2014 $18.9M +$7.22M +61.6% Nov 30, 2014 20-F 2016-03-21
Q1 2014 $16.3M Feb 28, 2014 6-K 2014-04-14
Q4 2013 $11.7M +$5.59M +91.3% Nov 30, 2013 20-F 2015-02-27
Q4 2012 $6.13M +$5.98M +4065% Nov 30, 2012 20-F 2014-02-18
Q4 2011 $147K +$130K +767% Nov 30, 2011 20-F/A 2013-02-01
Q4 2010 $17K* Nov 30, 2010 20-F 2012-05-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.